RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
RAPID MICRO BIOSYSTEMS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.77+0.01 (+1.20%)
Close on Oct 19, 2026
- Market cap
- $37.40M
- P/E (TTM)
- –
- Dividend yield
- –
RAPID MICRO BIOSYSTEMS, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Product | $23.43M | $18.73M | $14.81M | $11.06M | $15.51M | $10.99M | 69.7% | +25.1% |
| Service | $10.16M | $9.32M | $7.71M | $6.08M | $6.13M | $3.09M | 30.3% | +9.0% |
| Non-commercial revenue | – | – | – | – | $1.60M | $1.99M | – | – |
| Product and service revenue - recurring | – | – | – | – | $7.82M | $3.91M | – | – |
| Product and service revenue - non-recurring | – | – | – | – | $13.82M | $10.18M | – | – |
| Non-commercial revenue - non-recurring | – | – | – | – | $1.60M | $1.99M | – | – |
| Non-commercial | – | – | – | $0 | $1.60M | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | $13.43M | $10.64M | $9.88M | $8.77M | $12.89M | $7.30M | 40.0% | +26.3% |
| Switzerland | $6.02M | $5.67M | $4.00M | $2.76M | $4.31M | $4.11M | 17.9% | +6.2% |
| All other countries | $5.77M | $6.64M | $3.97M | $2.96M | $4.33M | – | 17.2% | -13.1% |
| Germany | $5.77M | $3.05M | $2.12M | $2.65M | $1.70M | $1.92M | 17.2% | +89.2% |
| Japan | $2.60M | $2.05M | $2.56M | – | – | – | 7.7% | +26.4% |
| All other countries | – | – | – | – | $4.33M | $2.74M | – | – |
From the segment and revenue-disaggregation notes of Rapid Micro Biosystems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.